The need of a neonatal preparation for Chagas disease
- Autores
- Sosa-Estani, Sergio; Belizán, José M.; Althabe, Fernando; Rubinstein, Aldofo
- Año de publicación
- 2005
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Fil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias; Argentina.
Fil: Belizan, Jose M. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.
Fil: Althabe, Fernando. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.
Fil: Rubinstein, Aldofo. Institute for Clinical Effectiveness and Health Policy, Buenos Aires; Argentina.
We have read about the efforts and initiatives related to the design of drugs for parasitic diseases in McKerrow's article [1] with interest and expectation. One of the pressing needs in this area is for a neonatal preparation for Chagas disease. Satisfactory achievements have been made in Argentina in relation to the transmission of the disease by vectors and through blood transfusion [2,3]. Vertical transmission is now the great challenge in eradicating Chagas disease. Around 800–1,300 neonates infected with Trypanosmoma cruzi are born every year in our country [4]. Almost 99% of all births occur in hospital, thus allowing the detection of infants born with parasites immediately after birth. The initiation of treatment of these neonates before they and their mothers leave the hospital is a good strategy to obtain high treatment coverage. The later attendance of mothers with their children to health-care facilities is quite unpredictable and irregular. Also, it is difficult to link information about maternal and neonatal parasitic status obtained at birth with later attendance at other health-care facilities. - Fuente
- PLoS medicine 2005; 2(11):e387.
- Materia
-
Recién Nacido
Enfermedad de Chagas - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- Repositorio
- Institución
- Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
- OAI Identificador
- oai:sgc.anlis.gob.ar:Publications/123456789/2153
Ver los metadatos del registro completo
id |
SGCANLIS_8b2ee880df098d131a70abd358ee7477 |
---|---|
oai_identifier_str |
oai:sgc.anlis.gob.ar:Publications/123456789/2153 |
network_acronym_str |
SGCANLIS |
repository_id_str |
a |
network_name_str |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
spelling |
The need of a neonatal preparation for Chagas diseaseSosa-Estani, SergioBelizán, José M.Althabe, FernandoRubinstein, AldofoRecién NacidoEnfermedad de ChagasFil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias; Argentina.Fil: Belizan, Jose M. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.Fil: Althabe, Fernando. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina.Fil: Rubinstein, Aldofo. Institute for Clinical Effectiveness and Health Policy, Buenos Aires; Argentina.We have read about the efforts and initiatives related to the design of drugs for parasitic diseases in McKerrow's article [1] with interest and expectation. One of the pressing needs in this area is for a neonatal preparation for Chagas disease. Satisfactory achievements have been made in Argentina in relation to the transmission of the disease by vectors and through blood transfusion [2,3]. Vertical transmission is now the great challenge in eradicating Chagas disease. Around 800–1,300 neonates infected with Trypanosmoma cruzi are born every year in our country [4]. Almost 99% of all births occur in hospital, thus allowing the detection of infants born with parasites immediately after birth. The initiation of treatment of these neonates before they and their mothers leave the hospital is a good strategy to obtain high treatment coverage. The later attendance of mothers with their children to health-care facilities is quite unpredictable and irregular. Also, it is difficult to link information about maternal and neonatal parasitic status obtained at birth with later attendance at other health-care facilities.Yes2005-11info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf1549-1676https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297548/pdf/pmed.0020387.pdfhttp://sgc.anlis.gob.ar/handle/123456789/215310.1371/journal.pmed.0020387PLoS medicine 2005; 2(11):e387.reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISPLoS medicineenginfo:eu-repo/semantics/openAccess2025-09-29T14:30:39Zoai:sgc.anlis.gob.ar:Publications/123456789/2153Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-09-29 14:30:40.213Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false |
dc.title.none.fl_str_mv |
The need of a neonatal preparation for Chagas disease |
title |
The need of a neonatal preparation for Chagas disease |
spellingShingle |
The need of a neonatal preparation for Chagas disease Sosa-Estani, Sergio Recién Nacido Enfermedad de Chagas |
title_short |
The need of a neonatal preparation for Chagas disease |
title_full |
The need of a neonatal preparation for Chagas disease |
title_fullStr |
The need of a neonatal preparation for Chagas disease |
title_full_unstemmed |
The need of a neonatal preparation for Chagas disease |
title_sort |
The need of a neonatal preparation for Chagas disease |
dc.creator.none.fl_str_mv |
Sosa-Estani, Sergio Belizán, José M. Althabe, Fernando Rubinstein, Aldofo |
author |
Sosa-Estani, Sergio |
author_facet |
Sosa-Estani, Sergio Belizán, José M. Althabe, Fernando Rubinstein, Aldofo |
author_role |
author |
author2 |
Belizán, José M. Althabe, Fernando Rubinstein, Aldofo |
author2_role |
author author author |
dc.subject.none.fl_str_mv |
Recién Nacido Enfermedad de Chagas |
topic |
Recién Nacido Enfermedad de Chagas |
dc.description.none.fl_txt_mv |
Fil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias; Argentina. Fil: Belizan, Jose M. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina. Fil: Althabe, Fernando. Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires; Argentina. Fil: Rubinstein, Aldofo. Institute for Clinical Effectiveness and Health Policy, Buenos Aires; Argentina. We have read about the efforts and initiatives related to the design of drugs for parasitic diseases in McKerrow's article [1] with interest and expectation. One of the pressing needs in this area is for a neonatal preparation for Chagas disease. Satisfactory achievements have been made in Argentina in relation to the transmission of the disease by vectors and through blood transfusion [2,3]. Vertical transmission is now the great challenge in eradicating Chagas disease. Around 800–1,300 neonates infected with Trypanosmoma cruzi are born every year in our country [4]. Almost 99% of all births occur in hospital, thus allowing the detection of infants born with parasites immediately after birth. The initiation of treatment of these neonates before they and their mothers leave the hospital is a good strategy to obtain high treatment coverage. The later attendance of mothers with their children to health-care facilities is quite unpredictable and irregular. Also, it is difficult to link information about maternal and neonatal parasitic status obtained at birth with later attendance at other health-care facilities. |
description |
Fil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias; Argentina. |
publishDate |
2005 |
dc.date.none.fl_str_mv |
2005-11 |
dc.type.none.fl_str_mv |
info:ar-repo/semantics/articulo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
1549-1676 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297548/pdf/pmed.0020387.pdf http://sgc.anlis.gob.ar/handle/123456789/2153 10.1371/journal.pmed.0020387 |
identifier_str_mv |
1549-1676 10.1371/journal.pmed.0020387 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297548/pdf/pmed.0020387.pdf http://sgc.anlis.gob.ar/handle/123456789/2153 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
PLoS medicine |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Yes |
publisher.none.fl_str_mv |
Yes |
dc.source.none.fl_str_mv |
PLoS medicine 2005; 2(11):e387. reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" instacron:ANLIS |
reponame_str |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
collection |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
instname_str |
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" |
instacron_str |
ANLIS |
institution |
ANLIS |
repository.name.fl_str_mv |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" |
repository.mail.fl_str_mv |
biblioteca@anlis.gov.ar |
_version_ |
1844621859227697152 |
score |
12.559606 |